ADORA2B and irritable bowel syndrome: Recent animal studies indicate that sustained activation of adenosine A2B receptors on myeloid cells could transactivate nociceptors of sensory neurons (28), and that systemic administration of A2B antagonists (MRS-1754 and PSB-1115) could reduce pain in response to stress in irritable bowel syndrome (29).